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Abstract

Key Points

IMPORTANCE Diversion of cerebrospinal fluid (CSF) has been used for decades as a treatment for
children with severe traumatic brain injury (TBI) and is recommended by evidenced-based

Question Is cerebrospinal fluid (CSF)
diversion associated with improved
outcomes or intracranial pressure in

guidelines. However, these recommendations are based on limited studies.

children with severe traumatic brain

OBJECTIVE To determine whether CSF diversion is associated with improved Glasgow Outcome

injury (TBI)?

Score–Extended for Pediatrics (GOS-EP) and decreased intracranial pressure (ICP) in children with

Findings In this comparative

severe TBI.

effectiveness study of 1000 children
with severe TBI, there was no

DESIGN, SETTING, AND PARTICIPANTS This observational comparative effectiveness study was

association between CSF diversion and

performed at 51 clinical centers that routinely care for children with severe TBI in 8 countries (US,

Glasgow Outcome Score–Extended for

United Kingdom, Spain, the Netherlands, Australia, New Zealand, South Africa, and India) from

Pediatrics at 6 months after injury in

February 2014 to September 2017, with follow-up at 6 months after injury (final follow-up, October

propensity-matched participants.

22, 2021). Children with severe TBI were included if they had Glasgow Coma Scale (GCS) scores of 8

However, CSF diversion was associated

or lower, had intracranial pressure (ICP) monitor placed on-site, and were aged younger than 18

with decreased intracranial pressure in

years. Children were excluded if they were pregnant or an ICP monitor was not placed at the study

the propensity-matched participants.

site. Consecutive children were screened and enrolled, data regarding treatments were collected,
and at discharge, consent was obtained for outcomes testing. Propensity matching for pretreatment
characteristics was performed to develop matched pairs for primary analysis. Data analyses were
completed on April 18, 2022.

Meaning These findings suggest that
the current evidenced-based guidelines
that support CSF diversion as a firstline therapy for TBI in children should be
reconsidered.

EXPOSURES Clinical care followed local standards, including the use of CSF diversion (or not), with
patients stratified at the time of ICP monitor placement (CSF group vs no CSF group).
MAIN OUTCOMES AND MEASURES The primary outcome was GOS-EP at 6 months, while ICP was
considered as a secondary outcome. CSF vs no CSF was treated as an intention-to-treat analysis, and
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a sensitivity analysis was performed for children who received delayed CSF diversion.
RESULTS A total of 1000 children with TBI were enrolled, including 314 who received CSF diversion
(mean [SD] age, 7.18 [5.45] years; 208 [66.2%] boys) and 686 who did not (mean [SD] age, 7.79
[5.33] years; 437 [63.7%] boys). The propensity-matched analysis included 98 pairs. In propensity
score–matched analyses, there was no difference between groups in GOS-EP (median [IQR]
difference, 0 [−2 to 3]; P = .40), but there was a decrease in overall ICP in the CSF group (mean [SD]
difference, 3.98 [0.14] mm Hg; P < .001).
CONCLUSIONS AND RELEVANCE In this comparative effectiveness study, CSF diversion was not
associated with improved outcome at 6 months after TBI, but a decrease in ICP was observed. Given
(continued)
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Abstract (continued)

the higher quality of evidence generated by this study, current evidence-based guidelines related to
CSF diversion should be reconsidered.
JAMA Network Open. 2022;5(7):e2220969.
Corrected on August 31, 2022. doi:10.1001/jamanetworkopen.2022.20969

Introduction
Drainage of cerebrospinal fluid (CSF) for neurosurgical emergencies, called CSF diversion, was first
described in 1774,1,2 and it remains one of the most common neurosurgical procedures for
neurological conditions, including traumatic brain injury (TBI).3 Removing CSF can lead to decreases
in intracranial pressure (ICP),4 and uncompensated increases in ICP can impair cerebral perfusion
and lead to adverse outcomes. Placement of devices to drain CSF can allow for ICP measurement at
the bedside, while intraparenchymal ICP catheters are also available to measure ICP without
performing CSF diversion. The risk-benefit decision for which device to place is central to
contemporary neurocritical care.
Seminal studies demonstrated associations between intracranial hypertension and mortality
after TBI, and these studies concurrently led to recommendations for CSF diversion as a treatment
strategy.5-8 Subsequently, 7 versions of evidenced-based guidelines for severe TBI for adults9-12 and
children13-15 suggest use of CSF diversion. The current recommendation for children is that that CSF
drainage through an external ventricular drain (EVD) is suggested to manage increased ICP based on
data from 56 children in 3 published reports.15 Because of the weakness of the evidence,16 we sought
to determine the associations between CSF diversion and neurological outcomes in children with
severe TBI. After conducting a survey of 32 pediatric centers to determine their current practices
related to CSF diversion, we found substantial intercenter and intracenter variability, strongly
suggesting a lack of equipoise that would imperil a randomized study design.17 Therefore, we
conducted an observational comparative effectiveness study using propensity matching to test the
primary hypothesis that CSF diversion is associated with improved outcomes after severe TBI. As a
secondary hypothesis, we sought to determine if CSF diversion in these matched patients is
associated with decreased ICP.

Methods
Study Design
The Approaches and Decisions for Acute Pediatric TBI (ADAPT) trial was an observational
comparative effectiveness study funded by a cooperative agreement with the US National Institute
of Neurological Disorders and Stroke). The study included sites in the US, United Kingdom, Spain, the
Netherlands, India, South Africa, Australia, and New Zealand (eTable 1 in Supplement 1). All sites
obtained institutional human research review board approval (institutional review board or
equivalent), and the University of Pittsburgh received institutional review board approval to
coordinate the study. All sites were permitted to perform data collection, including therapies that
were administered as standard of care prior to informed consent. Families were approached for
informed consent for outcome assessments at the time of ICU discharge. Therefore, this cohort
represents consecutive children meeting inclusion and exclusion criteria. We followed the
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting
guideline.
The inclusion criteria were age younger than 18 years, diagnosis of TBI, CP monitor placed, and
Glasgow Coma Scale (GCS) score of 8 or less at the time of monitor placement. Because we intended
ADAPT to inform the evidenced-based guidelines for severe TBI and many of the guideline topics are
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related to ICP-based therapies, we limited inclusion to children who had ICP monitors placed as part
of their clinical care. Importantly, sites chose the ICP monitoring modality (EVD devices that measure
ICP and perform CSF diversion or intraparenchymal devices that measure ICP but cannot perform
CSF diversion) at their discretion. We recorded the GCS score at the time of ICP monitoring to ensure
that all participants met the current definition for severe TBI (GCS score ⱕ8). Exclusion criteria were
pregnancy (to avoid potential confounding of therapies for TBI with pregnancy-related concerns)
and ICP monitor placement at another institution (to ensure data availability for early therapies
administered).
Data collection occurred during the prehospital phase (defined as the time of injury until arrival
at the study site), resuscitation phase (defined as arrival time at study hospital until ICP monitor
placement), ICP therapy phase (defined as time of ICP monitor placement until either 7 days or ICP
monitor removal), hospital phase (defined as the end of the ICP monitoring phase until hospital
discharge), and follow-up phase (defined as 6 months after ICP monitor placement time), as
previously reported.18-20 Patient demographics, injury details, imaging findings, severity of illness
scores, and prehospital and resuscitation events were collected consistent with the National Institute
of Neurological Disorders and Stroke TBI Common Data Elements (CDE)21-23 (eTable 2 in
Supplement 1). To assess if CSF strategies were associated with complications, we collected data on
general, cardiovascular, respiratory, and neurological complications after ICP monitor placement
(eTable 3 in Supplement 1). A variety of methods were used to determine the Glasgow Outcome
Score–Extended for Pediatrics (GOS-EP) scores from study participants. From consented
participants, site personnel assessed GOS-EP by phone, as previously described.24 If consented
participants were not available or parents refused outcomes assessments but allowed continuing
review of medical information, then medical records were reviewed for outcomes determination.
Sites recorded information regarding all neurosurgical procedures that occurred, including
insertion of an EVD. Sites recorded the strategy of CSF diversion (CSF diversion group vs no CSF
diversion group) at the time of ICP monitor placement and this strategy was used as an intention-totreat decision for this analysis (eTable 2 in Supplement 1). Participants who received continuous or
intermittent CSF diversion were considered as receiving CSF diversion for this analysis. If participants
who were treated without CSF diversion at the time of ICP monitor placement received CSF diversion
later in their hospital course, this information was collected, but the participants remained in the no
CSF diversion group for the primary analyses. A sensitivity analysis was performed to determine if
delayed CSF diversion was associated with different outcomes. Similar results would indicate that the
results are robust and not impacted by the time with the ICP monitor was placed. Hourly ICP readings
were recorded, and these values were used for the secondary analysis.

Statistical Methods
Baseline characteristics were summarized for each group and compared with independent sample t
test (or Wilcoxon Rank Sum test) or χ2 test (or Fisher exact test). Bivariate regression (proportional
odds, logistic, and Cox proportional hazards) models were used to assess the strength of the
association of CSF diversion with each outcome (GOS-EP, mortality, time to death, and
complications). A concern with observational studies is that there are confounders and biases
associated with treatment allocation (eg, higher severity of injury may be related to receiving the
intervention). Propensity score analysis was used to reduce the potential impact of confounding and
selection bias effects. The propensity score is the probability of treatment assignment conditional
on observed baseline characteristics. We estimated the propensity scores using the generalized
boosted models (GBM) approach25,26 and considered all characteristics collected. We used the
Toolkit for Weighting and Analysis of Nonequivalent Groups (twang) software package (RAND)27 and
SAS macros (SAS Institute) to estimate and evaluate the propensity scores. Propensity-matched
analysis with a 1:1 ratio was used to compare the outcomes of interest. We allowed a maximum of 3
splits for each tree in the model, allowing for 3-way interactions among all covariates to be
considered. The shrinkage parameter was set to 0.005 to ensure a smooth fit. Balance tables and
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plots were used to assess the quality of the propensity scores, to compare the propensity score
distributions between treatment groups, and to evaluate the common support. From the GBM
approach, a propensity score indicating the probability of CSF diversion strategy (yes or no) given
observed baseline characteristics was obtained for each participant. Caliper matching without
replacement within specified calipers of the logit of the propensity score was used for propensity
score matching.28,29
The primary outcome of the study was GOS-EP scores at 6 months. Other end points were
evaluated as exploratory, and no adjustments for multiple comparisons were made. For our primary
outcome of propensity-matched participants, the signed rank test was used to test the association of
group with GOS-EP score. An ordinal regression model was then used to estimate the association of
CSF diversion with GOS-EP score after controlling for characteristics not balanced through
matching.30 After propensity matching, a conditional logistic regression model was used to assess
the association of propensity-matched CSF group with mortality and complications. A conditional
Cox proportional hazards model was used to assess the association of propensity-matched CSF
group with time to death. Baseline characteristics that were unbalanced after matching by
propensity score were included in the models. As a sensitivity analysis, a combination of inverse
probability of received treatment weighting and unbalanced covariate adjustment (ie, doubly robust
estimation31) was performed if the propensity scores were not able to completely balance
participants’ characteristics for all outcomes. A similar analysis was performed as a sensitivity analysis
to assess the effect of including children with delayed CSF diversion in the CSF diversion group. In an
effort to broaden the number of participants included in the matched analysis, an additional
sensitivity analysis was conducted excluding a subsample of participants not likely to receive the
intervention. A classification tree model was used to identify subgroups who were not likely to
receive CSF diversion. The independent variables in the classification tree were those that were
included in the primary propensity score model. A propensity model was then fit using the
independent variables included in the propensity score from the primary analysis. This analysis also
resulted in a limited number of matched pairs. To increase the area of common support and number
of matched pairs, the propensity model was restricted to characteristics that were associated with
both the outcome and the exposure.
A longitudinal mixed effects regression model was used to compare the mean ICP over time
between groups. The model included a main fixed effect for and indicator of CSF diversion therapy
and a random effect for matched pair. All tests were 2-sided, and the significance level was set at
P = .05. All analyses were conducted using SAS software version 9.3 (SAS Institute). Data were
analyzed from [placeholder] to [placeholder].

Results
A total of 1018 children were screened for inclusion, and 18 children were excluded for having an ICP
monitor placed outside of a study site (Figure 1). A total of 1000 children with TBI were enrolled,
including 314 who received CSF diversion (mean [SD] age, 7.18 [5.45] years; 208 [66.2%] boys) and
686 who did not (mean [SD] age, 7.79 [5.33] years; 437 [63.7%] boys) (Table 1). The number of
participants for whom outcomes could not be determined was similar between groups (Figure 1)
yielding 246 participants in the CSF diversion group and 523 participants in the no CSF diversion
group available for analysis. After propensity matching, 98 matched pairs were identified.
Comparisons of characteristics in the overall cohort and the matched sample are summarized in
Table 1. For the overall cohort, an unadjusted bivariate ordinal logistic regression model
demonstrated that CSF diversion was associated with worse GOS-EP scores (odds ratio [OR], 1.36
[95% CI, 0.95-1.96]) and increased mortality at 28 days (OR, 1.26 [95% CI, 0.85-1.86]) (Table 2).
After adjustment for factors not balanced between groups (Hispanic ethnicity, pupil size, partial
pressure of blood oxygen monitor, decompressive craniectomy, extra-axial hematoma, intracranial
hemorrhage, pediatric hospital, electronic health record, and site), these associations were not
JAMA Network Open. 2022;5(7):e2220969. doi:10.1001/jamanetworkopen.2022.20969 (Reprinted)
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observed (GOS-EP: adjusted OR, 1.18 [95% CI, 0.71-.95]; mortality: adjusted OR, 0.74 [95% CI, 0.421.31]) (Table 2).
In the propensity-matched analysis, there was no difference in the primary outcome between
the groups (median [IQR] difference in GOS-EP score, 0 [−2 to 3]) (Table 3). The lack of a difference
persisted after controlling for characteristics not balanced through matching (parameter estimate,
0.8574 [95% CI, −1.2165 to 2.9312]; P = .96). There was no difference for death at 28 days (OR, 1.18
[95% CI, 0.62-2.52]; P = .62) or time to death (hazard ratio [HR], 1.15 [95% CI, 0.66-2.02]; P = .61) in
adjusted analysis or after adjusting for characteristics not balanced after propensity matching (race,
Hispanic ethnicity, injury severity score, time to ICP monitor placement) (28-day mortality: OR, 0.50
[95% CI, 0.21-1.18]; P = .11; time to death: HR, 0.55 [95% CI, 0.26-1.16]; P = .12) (Table 3). KaplanMeier estimates of the time to death were not significantly different between groups (eFigure 1 in
Supplement 1). A total of 62 children received delayed CSF diversion, defined as CSF diversion
occurring after the initial ICP monitor was placed. A sensitivity analysis including these children in the
CSF diversion group did not demonstrate differences between groups (median [IQR] difference in
GOS-EP score, 0 [−2 to 3]; P = .09) (eFigure 2 and eTable 4 in Supplement 1). In the second sensitivity
analysis, a classification tree identified 2 subgroups unlikely to receive the intervention: participants
from non-US sites (21 of 295 participants [7.1%] had CSF diversion), and participants from a US site
with a mean annual enrollment of fewer than 25 participants and an Abbreviated Injury Scale
abdomen score greater than 0 (4 of 39 participants [10.3%] had CSF diversion). This resulted in 148
matched pairs. Outcomes were not different between matched pairs (median [IQR] difference in
GOS-EP, 0 [−2 to 3]; P = .95) (eFigure 3 in Supplement 1). Using 21 000 hourly ICP readings for the
matched cohort, the mean (SD) difference between groups was 4.89 (12.79) mm Hg (95% CI, 4.535.24 mm Hg; P < .001) (Figure 2) over the study period, with the ICP was lower in the CSF diversion
group compared with the no CSF diversion group.

Discussion
In this comparative effectiveness study, the most comprehensive analysis of children with severe TBI
to our knowledge, there was no association of CSF diversion with improved overall outcomes at 6
months after injury. However, in an exploratory analysis, we found an association between CSF

Figure 1. Participant Recruitment Flowchart
1018 Patients assessed for eligibility
18 Excluded because ICP monitor placed outside
study hospital
1000 Enrolled

314 Received CSF diversion at ICP monitor placement

686 Did not receive CSF diversion at ICP monitor
placement

68 Outcome not obtained
54 Parents refused consent, unable to obtain
outcome from medical record
14 Parents consented, lost to follow-up

163 Outcome not obtained
126 Parents refused consent, unable to obtain
outcome from medical record
37 Parents consented, lost to follow-up

246 Inverse probability of treatment weighting
sensitivity analysis

523 Inverse probability of treatment weighting
sensitivity analysis

98 Propensity score–matched analysis

98 Propensity score–matched analysis
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Table 1. Baseline Participant Characteristics
Matched samplea

Full sample
CSF Diversion, No. (%)

CSF Diversion, No. (%)

Yes (n = 314)
7.18 (5.45)

No (n = 686)
7.79 (5.33)

Girls

106 (33.8)

249 (36.3)

Boys

208 (66.2)

437 (63.7)

Black

77 (26.5)

136 (21.7)

White

191 (65.6)

370 (59.0)

Otherb

23 (7.9)

121 (19.3)

48 (19.1)

63 (17.7)

Characteristic
Age, y, mean (SD)

P value
.10

Yes (n = 98)
6.69 (5.34)

No (n = 98)
7.33 (5.58)

P value
.42

Sex
.44

33 (33.7)

38 (38.8)

65 (66.3)

60 (61.2)

.46

Primary race

Hispanic ethnicityc

<.001
.65

24 (27.0)

24 (25.5)

53 (59.6)

67 (71.3)

12 (13.5)

3 (3.2)

8 (12.5)

23 (26.7)

.03
.03

Cause of injury
Motor vehicle

158 (50.3)

399 (58.2)

52 (53.1)

52 (53.1)

Fall

46 (14.6)

135 (19.7)

16 (16.3)

21 (21.4)

Homicide/assault

60 (19.1)

87 (12.7)

22 (22.4)

16 (16.3)

Other

50 (15.9)

65 (9.5)

8 (8.2)

9 (9.2)

Open

43 (13.7)

53 (7.7)

Closed

271 (86.3)

633 (92.3)

Acceleration/deceleration

27 (8.7)

68 (10.0)

Direct impact or fall

252 (81.6)

582 (85.7)

Penetrating

30 (9.7)

29 (4.3)

No concern

244 (77.7)

Possible

17 (5.4)

Probable

27 (8.6)

41 (6.0)

<.001

.64

Type of injury
.002

10 (10.2)

9 (9.2)

88 (89.8)

89 (90.8)

.81

Mechanism of injury
10 (10.2)

15 (15.3)

82 (83.7)

77 (78.6)

6 (6.1)

6 (6.1)

578 (84.3)

75 (76.5)

77 (78.6)

30 (4.4)

5 (5.1)

6 (6.1)

10 (10.2)

8 (8.2)

.003

.56

Likelihood injury due to abuse

Definite

.08

.94

26 (8.3)

37 (5.4)

8 (8.2)

7 (7.1)

Glasgow Coma Scale score, mean (SD)

4.83 (1.76)

5.32 (1.84)

<.001

4.88 (1.82)

4.91 (1.75)

.90

Injury severity score, mean (SD)d

27.1 (11.6)

26.8 (11.7)

.71

26.4 (10.9)

30.2 (13.1)

.03

Time between injury and monitor placement,
median (IQR), h
Cardiac arrest

5.25 (3.75-8.20)

6.98 (4.62-11.5)

<.001

6.23 (3.83-9.13)

5.92 (4.33-11.0)

<.001

32 (10.2)

49 (7.1)

.10

12 (12.2)

11 (11.2)

.82

Pediatric Risk of Mortality score, III, mean (SD)

17.8 (9.86)

16.7 (8.70)

.09

18.3 (9.72)

16.1 (9.29)

.11

Left

3.47 (1.62)

3.16 (1.44)

.004

3.54 (1.76)

3.08 (1.41)

.05

Right

3.54 (1.64)

3.19 (1.37)

.001

3.42 (1.59)

3.29 (1.44)

.57

Both

84 (26.8)

120 (17.5)

22 (22.4)

19 (19.4)

Either

29 (9.2)

66 (9.6)

10 (10.2)

10 (10.2)

Neither

183 (58.3)

443 (64.6)

64 (65.3)

62 (63.3)

Unable to assess or unknown

Pupil size, mean (SD), mm

Fixed pupils

.006

.39

18 (5.7)

57 (8.3)

2 (2.0)

7 (7.1)

Partial brain tissue oxygen

24 (7.6)

61 (9.0)

<.001

2 (2.2)

3 (3.2)

.65

Decompressive craniectomy

84 (26.8)

110 (16.2)

<.001

19 (19.4)

18 (18.4)

.86

Skull fracture

195 (63.5)

425 (64.5)

.77

60 (61.9)

52 (53.6)

.24

Extra-axial hematoma

246 (81.5)

469 (73.2)

.005

77 (80.2)

72 (75.0)

.39

Epidural hematoma

29 (9.4)

61 (9.3)

.93

8 (8.2)

6 (6.2)

.58

Subdural hematoma

225 (73.3)

431 (65.3)

.01

68 (70.1)

69 (71.1)

.87

Intracerebral

177 (57.7)

406 (61.6)

.24

55 (56.7)

48 (49.5)

.31

Intraventricular

98 (31.9)

142 (21.5)

<.001

27 (27.8)

23 (23.7)

.51

Subarachnoid

CT scan results

Hemorrhage

176 (57.3)

318 (48.3)

.008

60 (61.9)

54 (55.7)

.38

Midline shift supratentorial

125 (40.7)

218 (33.1)

.02

36 (37.1)

40 (41.2)

.56

Contusion

152 (49.5)

340 (51.6)

.55

40 (41.2)

42 (43.3)

.77

Penetrating injury

40 (13.0)

64 (9.7)

.12

11 (11.3)

9 (9.3)

.64
(continued)
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Table 1. Baseline Participant Characteristics (continued)
Matched samplea

Full sample
CSF Diversion, No. (%)

CSF Diversion, No. (%)

Yes (n = 314)

No (n = 686)

P value

Yes (n = 98)

No (n = 98)

P value

Free-standing children's hospital

256 (81.5)

446 (65.0)

<.001

83 (84.7)

84 (85.7)

.84

Uses electronic medical records

304 (96.8)

576 (84.0)

<.001

88 (89.8)

96 (98.0)

.01

Characteristic
Study hospital

Abbreviations: CSF, cerebrospinal fluid; CT, computed tomography.

c

Sites outside the US did not collect this information.

a

Matching was conducted using propensity score. Adjustments were made for Hispanic
ethnicity, pupil size, PbO2 monitor placement, decompressive craniectomy, extraaxial hematoma, intracranial hemorrhage, free-standing children’s hospital, electronic
health record, and site.

d

Calculated internally as the sum of the 3 highest squared Abbreviated Injury Scale body
region scores.

b

Includes Asian, Native Hawaiian or Pacific Islander, American Indian, and Alaska Native
or Inuit individuals and those whose race and ethnicity were unknown by the
research team.

Table 2. Bivariate Models of Primary and Secondary Outcomes, All Patients
Estimate (95% CI)a
Outcome

Unadjusted

P value

Adjustedb

P value

Glasgow Outcome Scale–Extended,
Pediatric Versionc,d

1.36 (0.95-1.96)

.09

1.18 (0.71-1.95)

.53

1.26 (0.85-1.86)

.25

0.74 (0.42-1.31)

.31

1.22 (0.86-1.73)

.26

0.78 (0.46-1.32)

.35

Respiratory

1.08 (0.72-1.62)

.70

0.84 (0.52-1.36)

.47

Cardiovascular

1.31 (0.79-2.19)

.29

1.05 (0.53-2.07)

.88

General

1.39 (0.90-2.13)

.13

0.97 (0.55-1.72)

.92

Neurological

1.24 (0.89-1.72)

.21

1.15 (0.75-1.76)

.52

Death

d

Time to deathe
Complicationsd

a

Included 769 participants for models of Glasgow Outcome Scale–Extended, Pediatric Version, 998 participants for
survival models, and 997 participants for models of complications.

b

Inverse probability of treatment weighting after adjusting for the following remaining imbalances: Hispanic ethnicity, left
and right pupil size, whether a partial pressure of blood oxygen monitor was placed, whether a decompressive
craniectomy for refractory intracranial pressure was performed, the presence or absence of an extra-axial hematoma, the
presence or absence of an intraventricular hemorrhage, whether the study hospital was a free-standing children’s
hospital, whether the study hospital used electronic medical records, and study site (when its inclusion did not result in a
quasicomplete separation of data points).

c

Higher scores indicate worse outcome.

d

Expressed as odds ratios. Odds ratios greater than 1 indicate greater odds of outcome for the CSF diversion group
compared with the no CSF diversion group.

e

Expressed as hazard ratios. Hazard ratios greater than 1 indicate greater risk of outcome for the CSF diversion group
compared with the no CSF diversion group per unit of time (days).

diversion and lower ICP. These findings may inform future recommendations for CSF diversion for
children with severe TBI.
CSF diversion has been used in children with severe TBI for decades, yet the recommendations
supporting its utility are based on limited studies. Shapiro and Marmarou32 published a case series
of 22 children with CSF diversion, reporting 22% mortality. However, the intent of this early report
was to demonstrate the utility of the pressure-volume index, rather than evaluating the effectiveness
of CSF diversion. A 2008 study in 23 children by Jagannathan and colleagues33 reported 13%
mortality and observed that most survivors achieved ICP control. A 2011 case series by Andrade and
colleagues34 reported outcomes of 11 children with continuous CSF diversion, but comparisons
between CSF diversion strategies were not performed.
CSF diversion is also recommended for adults with severe TBI, with recommendations that
continuous CSF diversion may be considered to lower ICP burden and CSF diversion may be
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considered within the first 12 hours for patients with GCS scores less than 6 to lower ICP. The studies
supporting these recommendations have similar limitations to those that inform the pediatric
guidelines. A study by Nwachuku and colleagues35 compared the effectiveness of continuous vs
intermittent CSF diversion in 62 participants (31 participants per group) and found that the
continuous CSF diversion group had improved ICP (5.66 mm Hg lower than the intermittent group)
and fewer episodes of intracranial hypertension. However, a comparison between diversion groups
was not performed. A study by Griesdale and colleagues36 compared 93 adults with CSF diversion
vs 73 adults without this therapy in an uncontrolled observational study. CSF diversion was
associated with increased mortality; however, subgroup analysis of patients with GCS scores less
than 6 showed some benefit, leading to one of the aforementioned recommendations stated.12 A
secondary analysis from 2019 by Bales et al37 assessed outcomes in the citicoline brain injury
treatment trial based on CSF diversion utilization. CSF diversion was performed at the discretion of
the site, and a comparison between participants who did and did not receive CSF diversion (224 and
123 participants, respectively) was performed. Bales et al37 found that CSF diversion was associated
with higher mortality and worse neuropsychological outcomes. The findings of our exploratory
analysis related to ICP, which was able to control for covariates and match patients based on relevant

Table 3. Models of Primary and Secondary Outcomes, Matched Patients
Matched by Propensity score (N = 98 pairs)
Outcome

Estimate

P value

Adjusted estimatea

Glasgow Outcome Scale–Extended,
Pediatric Version score, median (IQR)

0 (−2 to 3)

.40b

NA

NA

Death, OR (95% CI)c

1.18 (0.62 to 2.25)

.62

0.50 (0.21 to 1.18)

.11

Time to death, hazard ratio (95% CI)
per 1-d increasec

1.15 (0.66 to 2.02)

.61

0.55 (0.26 to 1.16)

.12

Respiratory

0.90 (0.49 to 1.68)

.75

0.93 (0.42 to 2.04)

.86

Cardiovascular

2.35 (0.78 to 7.04)

.13

2.14 (0.60 to 7.66)

.24

Abbreviations: NA, not applicable; OR, odds ratio.
a

Including primary race, Hispanic ethnicity, injury
severity score, and time between injury and
intracranial pressure monitor placement.

b

Wilcoxon signed-rank test.

c

Estimate greater than 1 indicates greater risk of
outcome for the CSF diversion group compared with
the no CSF diversion group.

Complications, OR (95% CI)c

General

1.08 (0.50 to 2.33)

.84

1.1 (0.39 to 3.04)

.86

Neurological

1.09 (0.61 to 1.94)

.77

1.26 (0.62 to 2.58)

.52

Figure 2. Intracranial Pressure (ICP) Response Between Groups
140
No CSF diversion
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F = 783, P < .001
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characteristics, suggest that CSF diversion could be useful to control intracranial hypertension early
after severe TBI in children, as some of these smaller adult studies have indicated.
Our study represents the highest quality of evidence regarding CSF diversion after TBI to out
knowledge. Although our study design could only detect associations between the therapy and
outcomes and could not discern cause and effect relationships, this method may be the most feasible
way to test the effectiveness of this therapy that is already part of contemporary practice. A
randomized clinical trial would be a superior method to determine the effectiveness of CSF diversion,
if such a study could be accomplished. However, several factors could hamper such a study. Since we
did not demonstrate a beneficial association of CSF diversion with overall outcome, estimating an
effect size to plan a randomized trial would be challenging. Equipoise regarding CSF diversion may
also be negatively impacted by our primary finding related to overall outcome, but our exploratory
analysis related to ICP may support such an approach.

Strengths and Limitations
This study has some strengths as well as limitations. As the largest prospectively enrolled study in this
population to our knowledge, we were able to adjust for many measured covariates that might affect
outcomes, including more than 1200 unique data elements. However, unmeasured covariates could
influence our findings. Our enrollment procedures allowed us to minimize selection bias by including
consecutive participants, but these methods limited our ability to obtain outcomes from all
participants. This limitation was mitigated to some degree by our follow-up procedures. Our broad
inclusion criteria and consecutive enrollment procedures intentionally included children who are
often not included in clinical trials, particularly those with penetrating injuries and with abusive head
trauma. While this limits the direct comparison of our study with some others, we thought it was
important to determine the overall effectiveness of CSF diversion in the entire pediatric TBI
population. Despite our large sample size, we were unable to stratify participants into subgroups
(GCS scores, sex, age) that might have demonstrated some benefit. While we were able to perform
sensitivity analyses, we were unable to evaluate if children with posttraumatic hydrocephalus would
benefit. Additionally, while the study included 1000 participants, the participant characteristics and
statistical methods yielded a limited number of participants for the primary analysis, which may limit
the generalizability of the results.

Conclusions
This comparative effectiveness study did not find a beneficial association of CSF diversion with
GOS-EP at 6 months after severe TBI in children. Further studies will be necessary to determine if
there are subsets of children who might benefit. However, in light of our findings, recommendations
for CSF diversion may need to be reconsidered.
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